Women with Stage 0 breast cancer who got biannual mammograms and delayed surgery for two years fared as well as those who got immediate surgery.

Early results from a clinical trial appear to confirm that most women with the precancerous breast condition known as ductal ...

In recent years, many researchers have been focused on DCIS: ductal carcinoma in situ, the earliest stage of cancer that in most cases remains in the milk ducts and does not invade other tissues.

Ductal carcinoma in situ, or DCIS, accounts for up to 25% of diagnosed breast cancers and affects more than 50,000 women each year, according to the American Cancer Society. Often called “sta ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront ...

“All current treatments for DCIS aim to reduce the risk of future invasive cancer, despite a growing body of evidence that not all DCIS is destined to progress,” said Dr. Shelley Hwang, a professor of ...

According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal carcinoma in situ (DCIS) resulted in breast cancer recurrence rates similar ...

Another in the Journal of the American Medical Association suggests a new approach to a type of breast cancer called ductal ...

Women who took tamoxifen after undergoing a lumpectomy to remove ductal carcinoma in situ (DCIS) were 44% to 51% less likely to have their cancer return in that breast, researchers reported last ...

SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the ...

SAN ANTONIO — For patients with so-called “good-risk” ductal carcinoma in situ (DCIS) who did not have radiation therapy after breast-conserving surgery, adjuvant tamoxifen reduced their ...

Another in the Journal of the American Medical Association suggests a new approach to a type of breast cancer called ductal carcinoma in situ, or DCIS. The research was discussed Thursday at the ...